The ROX index: “Propelled” by high-flow nasal cannula therapy during the COVID-19 pandemic into greater applicability in respiratory support
Main Authors: | Lucélia Luna Melo-Diaz, George Alvicio Kieling |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society of Respiratory Therapists
2022-11-01
|
Series: | Canadian Journal of Respiratory Therapy |
Subjects: | |
Online Access: | https://www.cjrt.ca/wp-content/uploads/cjrt-2022-012.pdf |
Similar Items
-
Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review
by: Daiana Gonçalves Arruda, et al.
Published: (2023-01-01) -
An Integrated Model including the ROX Index to Predict the Success of High-Flow Nasal Cannula Use after Planned Extubation: A Retrospective Observational Cohort Study
by: Young Seok Lee, et al.
Published: (2021-08-01) -
Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation index
by: Zhe Li, et al.
Published: (2022-06-01) -
ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study
by: Nattakarn Praphruetkit, et al.
Published: (2023-01-01) -
Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis
by: Chun En Yau, et al.
Published: (2023-08-01)